Endocannabinoid System Research and Clinical Psychosis Care
Clinical psychosis care benefits from understanding the endocannabinoid system's role in first-episode psychosis. Research highlights predictors of legal involvement during early psychosis. This knowledge aids targeted interventions to improve patient…
Endocannabinoid System Research: Trauma and Substance Use
Pre-trauma insomnia alcohol cannabis risk is a significant predictor of increased substance use following trauma exposure. Research shows that posttraumatic stress disorder partially mediates this relationship. Early identification and treatment of…
Cannabidiol Effects on Brain Excitability: Clinical Trial Findings
The cannabidiol anti epileptic properties clinical trial reveals CBD does not directly reduce cortical excitability at tested doses. This suggests its anti-seizure effects may depend on interactions with other medications like clobazam. These findings…
Endocannabinoid System & Sleep: Clinical RCT Evidence
This study presents oral cannabinoids sleep clinical trial evidence demonstrating that a single dose of THC and CBD reduced total sleep time in insomnia patients. The trial revealed suppression of REM sleep without next-day impairment. These findings…
Exploring Evidence on Cannabis Anxiety Treatment via Endocannabinoid System
This article reviews endocannabinoid system cannabis anxiety treatment evidence focusing on cannabinoid ratios and product formats. CBD-dominant products show more consistent anxiety relief than THC-heavy options. Understanding these differences aids in…
Impact of Cannabis Use on Trauma-Focused Treatment Outcomes
Cannabis use and trauma-focused treatment outcomes show comparable effectiveness for individuals with PTSD and substance use disorder. Evidence indicates cannabis does not significantly impair trauma-focused therapy results. This supports continued…
Endocannabinoid System Clinical Research: Evidence-Based Care
This article reviews endocannabinoid system clinical research cannabis RCT data highlighting evidence-based care approaches. The research supports digital mental health interventions for substance use and anxiety. These findings advance understanding of…
Endocannabinoid System Research: CBD and Glucose Tolerance
This cannabidiol glucose tolerance clinical trial examined the effects of low-dose CBD on glucose metabolism in sedentary adults with overweight or obesity. The study found no significant improvements in glucose tolerance or gut microbiome changes after…
Cannabinoid Clinical Trials: Evidence-Based Pediatric Care
Current evidence supports cannabinoid use in pediatric epilepsy, highlighting cannabidiol's efficacy in seizure disorders. Safety data remains limited outside epilepsy indications. Clinicians should focus on established pediatric cannabinoid use with…
Endocannabinoid System Research: Clinical Evidence Guide
Endocannabinoid system prenatal substance use research reveals complex interactions affecting fetal development. Polysubstance exposure during pregnancy complicates clinical counseling. Understanding these patterns is vital for risk stratification and…